EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of metabolic obesity phenotypes with cognitive decline in the ELSA ‐Brasil study

Paulo Henrique Lazzaris Coelho iD, Natalia Gomes Gonçalves, Itamar S Santos, Alessandra C Goulart, Sandhi Maria Barreto, Luana Giatti, Paulo Caramelli, Paulo Andrade Lotufo, Isabela Martins Bensenor, Claudia Kimie Suemoto

Diabetes, Obesity and Metabolism · 2026-04 · 28 (4) · 2849-2858

DOI: 10.1111/dom.70466 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 20.01.2026. Verfasst von Paulo Henrique Lazzaris Coelho und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Geriatrics, University of São Paulo Medical School, São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Obesity, Cognitive Dysfunction, Metabolic Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To investigate the association between metabolic obesity phenotypes and cognitive decline and evaluate the potential mediating role of C‐reactive protein (CRP).

Methods

Longitudinal cohort study using three waves (2008–2019) of the Brazilian Longitudinal Study of Adult Health (ELSA‐Brasil). Data were analysed from December 2024 to May 2025. Baseline sample consisted of 15 105 participants aged 35–74 years. Six phenotypes were defined by body mass index (BMI) category (normal weight, overweight, obesity) and metabolic health. Metabolic health was defined using traditional metabolic syndrome criteria and more stringent criteria: low waist‐to‐hip ratio (WHR), no diabetes or hypertension. Global cognition Z‐scores were derived from tests of memory (immediate, delayed recall, and recognition of a word list), verbal fluency (phonemic and semantic), and Trail‐Making tests (TMT‐B). Mediation analysis evaluated CRP as a potential mediator.

Results

Among 12 795 participants (mean age 51.1 years; 55% women; 53% White) followed for a median of 8 years, metabolically unhealthy phenotypes—across all BMI categories—were associated with faster cognitive decline (β estimates ranged from −0.037 to −0.053; all p < 0.001), whereas metabolically healthy overweight (β = 0.016; 95% CI = −0.002, 0.034; p = 0.081) and metabolically healthy obesity (β = 0.000; 95% CI = −0.027, 0.026; p = 0.981) were not. No evidence of CRP mediation was identified. BMI was not associated with cognitive decline (β = −0.001; 95% CI = −0.002, 0.000; p = 0.170), whereas WHR was (β = −0.020, 95% CI = −0.026, −0.014, p < 0.001).

Conclusions

Metabolic dysfunction may be a stronger predictor of subsequent cognitive decline than excess body weight. Dementia prevention strategies may benefit from early identification and management of metabolic dysfunction across all weight categories.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityCognitive DysfunctionMetabolic SyndromeHumansFemaleMaleLongitudinal StudiesMiddle AgedPhenotypeBrazilAgedC-Reactive ProteinAdultBody Mass Index

Stichwörter der Autor:innen

cohort studyelderlymacrovascular diseaseobesity careobservational studyweight management

Substanzen

C-Reactive Protein

Autor:innen und Institutionen

  • Division of Geriatrics, University of São Paulo Medical School, São Paulo, São Paulo, Brazil.
  • Preventive Medicine Department, University of São Paulo Medical School, São Paulo, São Paulo, Brazil.
  • Center for Clinical and Epidemiological Research, Hospital Universitário, University of São Paulo, São Paulo, São Paulo, Brazil.
  • Department of Preventive and Social Medicine & Clinical Hospital/EBSERH, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
  • Behavioral and Cognitive Neurology Unit, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

ORCID-Profile: Paulo Henrique Lazzaris Coelho

Zitieren

APA

Lazzaris Coelho, P. H., Gomes Gonçalves, N., Santos, I. S., Goulart, A. C., Barreto, S. M., Giatti, L., Caramelli, P., Lotufo, P. A., Bensenor, I. M., & Suemoto, C. K. (2026). Association of metabolic obesity phenotypes with cognitive decline in the ELSA ‐Brasil study. Diabetes, Obesity and Metabolism, 28(4), 2849-2858. https://doi.org/10.1111/dom.70466

Vancouver

Lazzaris Coelho PH, Gomes Gonçalves N, Santos IS, Goulart AC, Barreto SM, Giatti L, et al. Association of metabolic obesity phenotypes with cognitive decline in the ELSA ‐Brasil study. Diabetes, Obesity and Metabolism. 2026;28(4):2849-2858. doi:10.1111/dom.70466

BibTeX
@article{LazzarisCoelho2026,
  author = {Lazzaris Coelho, Paulo Henrique and Gomes Gonçalves, Natalia and Santos, Itamar S and Goulart, Alessandra C and Barreto, Sandhi Maria and Giatti, Luana and Caramelli, Paulo and Lotufo, Paulo Andrade and Bensenor, Isabela Martins and Suemoto, Claudia Kimie},
  title = {Association of metabolic obesity phenotypes with cognitive decline in the ELSA ‐Brasil study},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {4},
  pages = {2849--2858},
  doi = {10.1111/dom.70466}
}
Kostenlos starten →